POLYMERASE CHAIN REACTION MARKET ANALYSIS

Polymerase Chain Reaction Market, by Product Type (Instrument (Real Time PCR, Digital PCR, and Others) and Reagents and Consumables)), by End User (Clinical Diagnostics, Academic and Research Laboratories, Forensic Laboratories, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Published In : Jul 2022
Code : CMI1546
Pages :150
Formats :
Excel and PDF
Industry : Medical Devices

Market News

Global Polymerase Chain Reaction Market: Key Developments

In March 2022, according to the U.S. Food and Drug Administration (FDA), a new highly sensitive, easy-to-use test for COVID-19 that requires a single swab and 15 minutes has received emergency use authorization (EUA) status from the U.S. Food and Drug Administration (FDA). Rapid Polymerase Chain Reaction (PCR) test was developed in March 2022 at Northwestern University’s Center for Innovation in Global Health Technologies (CIGHT), the point-of-care technology is being commercialized by Northwestern spinoff company, Minute Molecular Diagnostics.